Back to the Learning Academy.

TSX Innovation European Roadshow

We're partnering with International Deal Gateway to support TSX and TSX Venture Exchange-listed companies in broadening their investor reach within the European market. The upcoming TSX Innovation Showcase, scheduled for May 27th-29th in Geneva, Zurich, and Milan, will connect select innovation-driven issuers with European-based family offices and high-net-worth investors.

This three-day roadshow offers a focused opportunity for companies across sectors like technology, healthcare, and clean tech to present their strategies to a European investor audience, potentially expanding their base of capital partners. As part of our commitment to supporting our listed companies, our sponsorship of this event enables participation at a reduced rate.

The TSX Innovation Showcase is an invitation-only event with limited availability. If your company is interested in exploring opportunities to broaden its investor reach in Europe through this initiative, please connect with our Company Services team at issuer.services@tmx.com for more information.

Related Articles

Is It Time To Switch Transfer Agents? A Decision Framework

Transfer agency service agreements typically run three to five years with renewal provisions. However, most Canadian issuers reach the re-evaluation moment at least once in the life of a transfer agent relationship, even if few act on it. Those who eventually do switch almost universally say they waited a year or two longer than they should have. Two signal categories tend to make the business case impossible to ignore.

Beyond the Lab: Life Sciences Spotlight by TSX

Canada is home to a dynamic, fast-growing biotech, healthcare, and medical innovation industry, with companies driving breakthroughs that are transforming lives and shaping the future of healthcare. Yet for many investors, the life sciences sector can seem difficult to navigate, with technical language and complex science creating barriers to understanding its full potential.